Google Alert - diet

News 1 new result for diet

Orexigen Falls After Halting Development of Diet Pill in U.S. Bloomberg Photographer: Tetsuya Yamada/Bloomberg Orexigen Therapeutics Inc. (OREX) slid the most in four months in Nasdaq trading after the drugmaker said it will halt US development of the diet pill Contrave because of uncertainty in the regulatory process. ... See all stories on this topic »

---

Tip: Use site restrict in your query to search within a site (site:nytimes.com or site:.edu). Learn more.

Remove this alert.
Create another alert.
Manage your alerts.